September 6, 2021
Sept 6, 2021
Coverage Updates
We generally don’t focus on the macro when writing our updates, but unfortunately, we can’t dive into company-specific updates without spending a minute on the poor market sentiment around biotech, […]
March 7, 2021
March 7, 2021 Update
Coverage Updates
We thought it timely to provide an update on our coverage universe. Many of our names have imminent catalysts that warrant investors’ attention. We also have two names that we […]
July 26, 2020
July 26, 2020 Update
Coverage Updates
Since our last update note in January, we have initiated on three new companies; TLC (Nasdaq: TLC), Delcath Systems (Nasdaq: DCTH), and Epigenomics (FSE: ECX.DE, OTC: EPGNF). This brings our […]
January 16, 2020
January 16, 2020 Update
Coverage Updates
Over the past 3-months we have initiated coverage on three companies; Xenon Pharmaceuticals (Nasdaq: XENE), ESSA Pharma (Nasdaq: EPIX), and Acasti Pharma (Nasdaq: ACST). After we issue our initiation reports, […]